Revolutionizing Clinical Data Analytics since 2003

MaxisIT empowers life sciences to reduce risk, time, and cost with integrated data management and analytics solutions.

About MAXIS AI

Maxis AI has introduced the First AIWorkforce for Clinical Trials, a supervised execution layer built for regulatedclinical environments.

Clinical development does not lackvisibility; it lacks scalable execution capacity, reliability, and consistentrisk mitigation. What limits progress is the ability to resolve operationalchallenges reliably and at scale.

Maxis enables sponsors and CROs to executedefined clinical workflows through governed AI agents operating under expert supervision. This model integrates with existing systems while ensuring controlled access, validation checkpoints, and accountability.

Built on experience from more than 3,300clinical trials, the platform supports operations across study startup,enrollment, data management, statistical programming, medical writing, and riskoversight.

OUR VISION

We envision a future where drug development will move closer to everyone making personalized and affordable medicine a practical reality rather than an expectation.Our vision beholds evolution of current manpower-limited scaling to supervised intelligent workforce systems as the foundation of regulated execution.Human expertise and intelligent systems will operate together to expand execution capacity, compress development timelines, and reduce the cost of innovation.This shift will compress development timelines, reshape cost structures, and bring targeted, personalized therapies within practical and economic reach.

Our Vision

We envision a future where drug development will move closer to everyone making personalized and affordable medicine a practical reality rather than an expectation.

Our vision beholds evolution of current manpower-limited scaling to supervised intelligent workforce systems as the foundation of regulated execution.

Human expertise and intelligent systems will operate together to expand execution capacity, compress development timelines, and reduce the cost of innovation.

This shift will compress development timelines, reshape cost structures, and bring targeted, personalized therapies within practical and economic reach.

Our Mission

Maxis AI exists to transform clinical development economics by removing execution constraints through a supervised AI Workforce embedded in regulated trial operations.

By 2027, we target up to a 27% reduction in per-patient development cost and a 36% acceleration in operational timelines without compromising governance, quality, or human oversight.

We elevate science by delivering consistent, transparent, and scalable execution across the clinical development lifecycle.

Designed to Think. Built to Act.

Maxis combines intelligent workfloworchestration with human oversight, audit traceability, and service level accountability, increasing throughput without proportional headcount growth.

By redefining execution capacity, Maxisaligns cost with output, improves portfolio predictability, and maintainsregulatory confidence.

Our mission is to advance a new operatingmodel for clinical development, helping innovative therapies reach patientsfaster with discipline, governance, and measurable impact.

OUR MISSION
Maxis AI exists to transform clinical development economics by removing execution constraints through a supervised AI Workforce embedded in regulated trial operations.

By 2027, we target up to a 27% reduction in per-patient development cost and a 36% acceleration in operational timelines without compromising governance, quality, or human oversight.

We elevate science by delivering consistent, transparent, and scalable execution across the clinical development lifecycle.

OUR MISSION

Maxis AI exists to transform clinical development economics by removing execution constraints through a supervised AI Workforce embedded in regulated trial operations.

By 2027, we target up to a 27% reduction in per-patient development cost and a 36% acceleration in operational timelines without compromising governance, quality, or human oversight.

We elevate science by delivering consistent, transparent, and scalable execution across the clinical development lifecycle.

OUR VISION

We envision a future where drug development will move closer to everyone making personalized and affordable medicine a practical reality rather than an expectation.Our vision beholds evolution of current manpower-limited scaling to supervised intelligent workforce systems as the foundation of regulated execution.Human expertise and intelligent systems will operate together to expand execution capacity, compress development timelines, and reduce the cost of innovation.This shift will compress development timelines, reshape cost structures, and bring targeted, personalized therapies within practical and economic reach.
OUR MISSION

Maxis AI exists to transform clinical development economics by removing execution constraints through a supervised AI Workforce embedded in regulated trial operations.

By 2027, we target up to a 27% reduction in per-patient development cost and a 36% acceleration in operational timelines without compromising governance, quality, or human oversight.

We elevate science by delivering consistent, transparent, and scalable execution across the clinical development lifecycle.

Looking for Agentic AI for clinical trials?

Explore our Agentic AI Platform to see how AI agents are transforming study startup, data management, oversight, and regulatory submissions.